Confinement and Spondyloarthritis Treatment
Impact of Confinement on the Treatment of Spondyloarthritis.
1 other identifier
observational
1,000
1 country
1
Brief Summary
Evaluate the impact of confinement on treatment use in spondyloarthritis. Study hypothesis that with the confinement, subjects will stop their treatment. The main objective is to study the impact of confinement on treatment. And secondly to look for for specific psychological profile linked to the interruption of the treatment. the study population consists of patients with spondyloarthritis and belonging to a patient association (ACS). All patients over 18 are included. A mailing questionnaire will be send to all patients. data on diseases activity and treatment will be collected
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 16, 2020
CompletedStudy Start
First participant enrolled
April 20, 2020
CompletedFirst Posted
Study publicly available on registry
April 21, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedJune 22, 2026
April 1, 2020
4 months
April 16, 2020
June 18, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
treatment use
treatment continuation
1 month
Secondary Outcomes (3)
activity of disease
1 week
psychological aspects
1 month
psychological aspects
1 month
Eligibility Criteria
patients with spondyloarthritis and member of ACS patient association group
You may qualify if:
- spondyloarthritis,
- age over 18 ans
- treatment by NSAID or biological treatment to be part of the patient association "ACS" (action contre les spondylarthropathies).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice
Nice, 06300, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 16, 2020
First Posted
April 21, 2020
Study Start
April 20, 2020
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
June 22, 2026
Record last verified: 2020-04
Data Sharing
- IPD Sharing
- Will not share
no data sharing plan has been established